FDA, NIDA call for marijuana legislation to advance public health

Leaders from the FDA and the National Institute on Drug Abuse said during a recent House Committee on Energy and Commerce hearing that there is a pressing need for federal laws that allow more research into marijuana, including research investigating the effects of different amounts of THC.
There are currently at least six bills in the U.S. House that have components that would decriminalize marijuana, remove it from the Drug Enforcement Administration’s Schedule I list of agents — which are classified as agents that have a high potential for abuse and no currently acceptable

Source link

Related posts

Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection


Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics


75% of indigestion patients reduce or stop PPIs after education, rescue therapy


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World